ICPMS
More information
WebinarsAbout usContact usTerms of use
LabRulez s.r.o. All rights reserved. Content available under a CC BY-SA 4.0 Attribution-ShareAlike
    1. Databases

    1. Industries

    1. Instrumentation

    1. Manufacturer

    1. Author

    1. Content Type

    1. Publication Date

    Applications from the field of Pharma & Biopharma from Shimadzu | LabRulez ICPMS

    Negative Mode Analysis of Synthetic Oligonucleotides using the MALDI-8030 Dual Polarity Benchtop MALDI-TOF Mass Spectrometer

    Applications
    | 2022 | Shimadzu
    MALDI, LC/TOF, LC/MS
    Instrumentation
    MALDI, LC/TOF, LC/MS
    Manufacturer
    Shimadzu
    Industries
    Pharma & Biopharma

    Structural Analysis of Impurities in Pharmaceuticals Using Trap-Free 2D HPLC and the LCMS-9030

    Applications
    | 2019 | Shimadzu
    LC/TOF, LC/HRMS, LC/MS, LC/MS/MS, 2D-LC
    Instrumentation
    LC/TOF, LC/HRMS, LC/MS, LC/MS/MS, 2D-LC
    Manufacturer
    Shimadzu
    Industries
    Pharma & Biopharma

    Structural Analysis of Impurities in Pharmaceuticals Using Trap-Free 2D HPLC and the LCMSTM -9030

    Applications
    | 2019 | Shimadzu
    LC/TOF, LC/HRMS, LC/MS, LC/MS/MS, 2D-LC
    Instrumentation
    LC/TOF, LC/HRMS, LC/MS, LC/MS/MS, 2D-LC
    Manufacturer
    Shimadzu
    Industries
    Pharma & Biopharma

    Distribution of active pharmaceutical ingredients in Forthysia suspensa and quality control with mass spectrometry imaging

    Posters
    | 2023 | Shimadzu (ASMS)
    MS Imaging, LC/TOF, LC/HRMS, LC/MS, LC/MS/MS
    Instrumentation
    MS Imaging, LC/TOF, LC/HRMS, LC/MS, LC/MS/MS
    Manufacturer
    Shimadzu
    Industries
    Pharma & Biopharma

    Enhancing the data quality by high-speed analysis on a single quadrupole mass spectrometer

    Posters
    | 2021 | Shimadzu (ASMS)
    LC/MS, LC/SQ
    Instrumentation
    LC/MS, LC/SQ
    Manufacturer
    Shimadzu
    Industries
    Pharma & Biopharma

    Highly sensitive LC-MS/MS method for the determination of NDMA, NDEA, NDIPA, NMBA, NEIPA and NDBA in Metformin drug substance

    Posters
    | 2020 | Shimadzu
    LC/MS, LC/MS/MS, LC/QQQ
    Instrumentation
    LC/MS, LC/MS/MS, LC/QQQ
    Manufacturer
    Shimadzu
    Industries
    Pharma & Biopharma

    Structural analysis of impurities in pharmaceutical ingredients using trap-free 2D-LC high-resolution accurate mass spectrometry

    Posters
    | 2019 | Shimadzu
    LC/TOF, LC/HRMS, LC/MS, LC/MS/MS, 2D-LC
    Instrumentation
    LC/TOF, LC/HRMS, LC/MS, LC/MS/MS, 2D-LC
    Manufacturer
    Shimadzu
    Industries
    Pharma & Biopharma

    Separation of Trypsin Digested Monoclonal Antibod

    Applications
    | 2022 | Shimadzu
    Consumables, LC/TOF, LC/HRMS, LC/MS, LC/MS/MS, LC columns
    Instrumentation
    Consumables, LC/TOF, LC/HRMS, LC/MS, LC/MS/MS, LC columns
    Manufacturer
    Shimadzu
    Industries
    Pharma & Biopharma

    Analysis of Drug Degradants by LC/MS

    Applications
    | N/A | Shimadzu
    HPLC, LC/MS, LC/SQ
    Instrumentation
    HPLC, LC/MS, LC/SQ
    Manufacturer
    Shimadzu
    Industries
    Pharma & Biopharma

    Separation of Trypsin Digested Monoclonal Antibody

    Applications
    | 2022 | Shimadzu
    Consumables, LC/TOF, LC/HRMS, LC/MS, LC/MS/MS, LC columns
    Instrumentation
    Consumables, LC/TOF, LC/HRMS, LC/MS, LC/MS/MS, LC columns
    Manufacturer
    Shimadzu
    Industries
    Pharma & Biopharma
     

    Related content


    From a scientific project to a global business venture. The company mzio is striving to improve data analysis in mass spectrometry labs

    We, 29.5.2024
    Ústav organické chemie a biochemie AV ČR

    Cryo-EM structures show how Trypanosomes escape the human innate immune response

    Tu, 28.5.2024
    Ústav organické chemie a biochemie AV ČR

    An innovative approach to planar chiral substances

    Mo, 27.5.2024
    Katedra organické chemie Přírodovědecké fakulty Univerzity Karlovy
    Other projects
    Follow us
    More information
    WebinarsAbout usContact usTerms of use
    LabRulez s.r.o. All rights reserved. Content available under a CC BY-SA 4.0 Attribution-ShareAlike